Investor relations has been less than stellar IMO. The companies balance sheet per the last 10K is ugly (yes I know start up no revenue is not unusual but it is 'what it is'). Dilution of 2 billion shares since late/early 2012/2013 respectively. ENTB going nowhere fast. Potential but no substantial progress (though one could debate that depending on their definition of progress). All these things are red flags IMO. And ridiculous I know, but Dr. Koos does not strike me as the most ambitious looking man in the world. Yet there is so much 'lining up' here. Additionally the medical doctors I have spoken to (all 2 of them!) also believe big things to come with this science - though they still see it a few years away. We will see soon - this could be amazing not only for investors but also for the patients that could benefit from this medicine. We will see soon!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.